Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone rebound therapy: a neglected modality.

C W Charny, J A Gordon

    Fertility and Sterility
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

    Genes, chromosomes & cancer·2019
    Same author

    Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults.

    Nutrition & diabetes·2017
    Same author

    Maternal immune activation does not alter the number of perisomatic parvalbumin-positive boutons in the offspring prefrontal cortex.

    Molecular psychiatry·2016
    Same author

    Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.

    Molecular psychiatry·2016
    Same author

    Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.

    Prostate cancer and prostatic diseases·2015
    Same author

    Achilles tendons from decorin- and biglycan-null mouse models have inferior mechanical and structural properties predicted by an image-based empirical damage model.

    Journal of biomechanics·2015

    Testosterone rebound therapy can restore fertility in over half of male patients, leading to pregnancies in 25% of couples. This effective treatment is underutilized and requires careful patient selection.

    Area of Science:

    • Reproductive endocrinology
    • Andrology
    • Men's health

    Background:

    • Testosterone therapy is commonly used for male hypogonadism.
    • Limited data exists on the long-term efficacy of testosterone rebound therapy for fertility restoration.
    • Patient selection is crucial for successful outcomes.

    Purpose of the Study:

    • To review the literature and present a 20-year experience with testosterone rebound therapy.
    • To evaluate the efficacy of testosterone rebound therapy in restoring sperm parameters and achieving pregnancies.
    • To assess the safety and long-term outcomes of this therapeutic approach.

    Main Methods:

    • A retrospective review of 225 patients undergoing testosterone rebound therapy over 20 years.
    • Analysis of sperm parameters, fertility rates, and pregnancy outcomes.

    Related Experiment Videos

  • Assessment of treatment-related adverse events and persistent azoospermia.

    • Main Results:

    • 52% of patients achieved fertile sperm counts after testosterone rebound therapy.
    • Pregnancies occurred in 25% of couples where the male partner received therapy.
    • Pregnancy was achieved in 8% of initially azoospermic patients.
    • Only 4% of patients experienced a return to pretreatment sperm counts, with no persistent azoospermia.

    Conclusions:

    • Testosterone rebound therapy is an effective, albeit neglected, treatment for selected male patients seeking fertility restoration.
    • High rates of sperm count recovery and pregnancy achievement support its consideration.
    • Proper patient screening and selection are mandatory for optimal results.